In summary, our study identified novel compound variants of the NR5A1 and MAP3K1 genes which can alter the expression of SOX9 and ultimately resulted in a specific phenotype of a patient with 46, XY DSD. This evidence concerns the gene SOX9 and disorder of sexual differentiation.